Knowledge (XXG)

Parexel

Source 📝

759: 27: 154: 248: 880:. Concerns were also raised about whether a safe human dosage was properly obtained by TeGenero. The MHRA however concluded that none of the companies involved could be held responsible for the outcome of the test and that the adverse events that occurred were most likely caused by an unpredicted biological action of the drug in humans. 221:
In 1990, the firm expanded internationally and established new practice areas. By 1999 it had a staff of 4,500 and 45 offices. In the 2000s, it grew to over 18,000 employees. Parexel's consulting and clinical trial work has helped establish many household drug brands and contributed to numerous
476:
providing software and services to the pharmaceutical and biotechnology industries, including DataWeb Enterprise Edition, a web-based data repository of potential clinical investigators combined with a decision support environment for initiating clinical
229:
The company was acquired by private equity firm Pamplona Capital Management for approximately $ 5.0 billion. The deal closed in September 2017. On July 2, 2021, Parexel announced a merger agreement under which it would be acquired by EQT IX fund and
209:
approval process. The firm has grown organically over the years and through 40 acquisitions. Josef von Rickenbach is credited with establishing Parexel's culture and practices based on the principles he experienced as a researcher at
856:
Parexel became the target of legal proceedings from lawyers representing the injured volunteers after the insurance policy of TeGenero was unable to provide sufficient compensation. When the liable company subsequently declared
1710:"PAREXEL Agrees to Acquire California Clinical Trials Medical Group, Inc., and Behavioral and Medical Research, LLC; Acquisition Adds West Coast Phase I Unit and Specialty Phase II – IV Clinical Research Services" 1430: 2162: 552:
for approximately $ 3.0 million plus additional payments of up to approximately $ 3.0 million in contingent purchase price if Qdot achieves certain established financial targets through September 28, 2008.
2006: 611:
whose business spans mainland China, Hong Kong, India, Taiwan, Singapore, Indonesia, South Korea, Malaysia, Thailand, the Philippines, New Zealand, and Australia, for around $ 50.9 million.
1052: 2209: 1404: 198:
clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling
1790: 2502: 1709: 1981: 873: 861:, lawyers for the volunteers initiated legal proceeding against Parexel and the two parties later entered into talks; the results of this meeting have not been made public. 735:, a provider of medical imaging, eClinical and regulatory solutions and services to solve complex challenges in clinical research, is launched as an independent company. 2517: 897: 1902: 1261: 2159: 1125: 1098: 385:, a physician-focused marketing and clinical communications firm servicing the international pharmaceutical industry, for $ 113.1 million in own common stock; 2202: 368:, a management consulting firm on FDA and other regulatory matters to the pharmaceutical, biotechnology and medical device industries based in Massachusetts. 205:
Parexel was founded in 1982 by Josef von Rickenbach and organic chemist Anne B. Sayigh initially to advise Japanese and German firms on how to navigate the
421:
announced it would acquire its competitor Parexel for $ 612.7 million in stock and combine the two drug research and development companies under the name
961: 2507: 1848: 1350: 2512: 357:, a Colorado corporation developing software for analyzing and measuring high resolution medical images, and announces its strategic alliance with 2195: 1653: 1070: 1482: 1759: 1509: 1234: 1207: 667: 327:, a Washington, D.C.-based provider of medical marketing and related consulting services to the health care and pharmaceutical industries. 1818: 932: 452: 2267: 2117: 1956: 1734: 1622: 768: 2232: 872:'s Dispatches series exposed uncertainty about the existence of data that should mandatorily have been submitted by TeGenero to the 801: 732: 633:
with additional offices in the United Kingdom, Germany and India, employing nearly 300 individuals, for approximately $ 72 million.
465:, a clinical research organization in Latin America with offices in Argentina and Brazil, for approximately $ 1.6 million in cash. 530: 1769: 1663: 1632: 1540: 202:
on the market today. The company publishes the annual Parexel R&D Statistical Sourcebook and operates the Parexel-Academy.
1179: 997: 2218: 731:
January 2021: Following the strategic separation of the Parexel Informatics business from Parexel International, a spin-off,
608: 391:, a full service, pan-European contract research organization based in the Netherlands, for $ 26 million in own common stock; 62: 1431:"PAREXEL Acquires Majority Interest in Clinical Pharmacology Research Business and Bioanalytical Laboratory in South Africa" 1323: 1457: 1126:"EQT Private Equity and Goldman Sachs Asset Management Complete Acquisition of Parexel | Parexel International Corporation" 696: 640:, a life sciences consultancy that provides commercialization services for biopharmaceutical companies, headquartered in 1015: 1876: 1910: 1856: 1593: 1561: 593: 1099:"Parexel to be Acquired by EQT Private Equity and Goldman Sachs Asset Management | Parexel International Corporation" 983: 2242: 2237: 444: 310:, a provider of remote data entry technology designed to enhance the quality and timeliness of clinical trial data. 414:
and employing approximately 70 people, in exchange for approximately 199,600 shares of the company's common stock.
2413: 2327: 1931: 772: 447:
for approximately $ 3.0 million. A few weeks later the company acquired a clinical pharmacology unit located in
2481: 2292: 485: 473: 2030: 1764: 1658: 1627: 1535: 1294: 541:, teleservices, call center services, fulfillment, focus group and database management, and market research. 448: 315:
August 1996: Parexel acquires in separate transactions for a combined 1,008,304 own shares of common stock:
199: 122: 1684: 397:, a provider of regulatory services to pharmaceutical manufacturers, for $ 3.9 million in own common stock. 1826: 1152: 842: 823: 94: 37: 332:
March 1997: Parexel acquires in separate transactions for a combined 210,000 own shares of common stock:
630: 98: 518:, a clinical research organization with expertise in Phase I and Phase IIa Proof-Of-Concept studies in 830: 706:, integrating its natural language processing and software development capabilities into the AI Labs. 549: 215: 1405:"PAREXEL Acquires the Phase I Clinical Research Business And Bioanalytical Laboratory of CEMAF S.A." 651:, a clinical research service provider in Turkey, the Middle East and North Africa headquartered in 2466: 2332: 2312: 2252: 2007:"Parexel Announces Acquisition of Leading Pharmacology Modeling & Analytics Firm Model Answers" 1530: 534: 2428: 2408: 2398: 2337: 2277: 1355: 850: 834: 497: 456: 2121: 876:(MHRA) prior to the trial indicating whether TGN1412 had been adequately tested on human blood 738:
November 2021: EQT and Goldman Sachs completed the acquisition of Parexel on November 15, 2021.
1791:"PAREXEL International Announces Acquisition of Liquent, Inc., and Updates Financial Guidance" 1299: 678: 533:, provider of professional marketing and communication services specialized in clinical trial 489: 141: 2262: 571: 433: 339: 1034: 2166: 618:, a provider of telephone and web-based systems used in clinical trials, headquartered in 562:
October 2006: Parexel forms a joint venture arrangement (taking 75% equity interest) with
538: 519: 406:, a French provider of post-regulatory services to pharmaceutical manufacturers, based in 211: 2096: 940: 644:, U.K., with additional offices in India, Sweden, and the U.S., for up to $ 38.2 million. 234:
for $ 8.5 billion. EQT and Goldman Sachs completed the acquisition on November 15, 2021.
2051: 2071: 911: 508: 361:
based in Belgium, specializing in intelligent optical character recognition technology.
195: 191: 133: 66: 1982:"Parexel Completes Purchase of Roam Analytics' Natural Language Processing Capability" 555:
August 2005: Parexel buys the remaining 2.2% of its information technology subsidiary
348:, a company located in the United Kingdom that specializes in biostatistical analysis. 2496: 2440: 2423: 2322: 819: 725: 724:
July 2021: Parexel is acquired by EQT IX fund and the Private Equity business within
663: 629:, a global provider of regulatory information management solutions, headquartered in 231: 137: 45: 443:, a clinical pharmacology research business and bioanalytical laboratory located in 2031:"Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services" 783: 418: 273: 223: 1377: 1289: 1071:"Pamplona Capital Management acquires Parexel International | Private Equity Wire" 2187: 2393: 2342: 1797: 26: 2142: 548:, a Phase I and IIa Proof of Concept clinical pharmacology business located in 2317: 1487: 1435: 1408: 1328: 1266: 1239: 1212: 1184: 865: 858: 714: 619: 493: 411: 1303: 2418: 2363: 2358: 2307: 1262:"PAREXEL Acquires Leading International Contract Marketing Services Company" 869: 845:
in six healthy volunteers at a facility based at Northwick Park Hospital in
838: 718: 589: 262: 1903:"Parexel to tap additional pharmacovigilance services with QSI acquisition" 898:"PAREXEL International Reports Fourth Quarter and Fiscal Year 2017 Results" 709:
February 2020: Parexel acquires Model Answers, a consultancy firm based in
688:, an independent life sciences strategy consulting firm with 120 employees. 998:"List of Public Companies Worldwide, Letter – Businessweek – Businessweek" 2403: 2378: 2272: 2257: 2056: 1382: 877: 815: 710: 652: 514:
March 2004: Parexel buys the remaining majority of outstanding shares of
258: 1654:"Parexel buys out remaining minority interest in Perceptive Informatics" 864:
A documentary shown in the UK on 28 September 2006 featuring journalist
2471: 2461: 2388: 2383: 2373: 2297: 2287: 826: 748: 728:
Asset Management from Pamplona Capital Management LP for $ 8.5 billion.
500:
with approximately employees, for approximately $ 1.7 million in cash.
432:, a Phase I clinical research and bioanalytical laboratory located in 2476: 2247: 962:"PAREXEL Biopharmaceutical Statistical Sourcebook 2014/2015 (eStats)" 846: 604: 596:
services through four clinical sites in California, for $ 65 million.
51: 1053:"BRIEF-Pamplona Capital Management completes acquisition of Parexel" 492:), a provider of specialized sales and marketing services based in 353:
November 1997: Parexel acquires substantially all of the assets of
190:
is an American provider of biopharmaceutical services. It conducts
2445: 2433: 2368: 2282: 1601: 1569: 1157: 933:"MoneyShow.com: TOP PROS' TOP PICKS – Parexel Puts Drugs on Trial" 641: 507:, a provider of software for clinical trial management systems in 407: 301: 603:(in which Parexel has held a minority stake since April 2003), a 2191: 1849:"Parexel taps Middle East, North Africa with Atlas acquisition" 752: 570:
transferred its clinical trial business operations located in
241: 206: 1735:"Parexel strengthens Asia-Pacific hand with Apex acquisition" 1562:"ACQUISITIONS AND IMPACT OF RESTRUCTURING AND OTHER CHARGES" 381:, a medical marketing firm based in the United Kingdom, and 436:
for an initial cash payment of approximately $ 3.0 million.
2182: 1483:"PAREXEL International Enhances Presence in Latin America" 982:
Applied Clinical Trials Editorial Staff (13 April 2015).
321:, a contract research organization located in Israel, and 1351:"COVANCE SAYS IT IS ACQUIRING PAREXEL FOR $ 612 MILLION" 1235:"PAREXEL Completes Acquisition of Kemper-Masterson, Inc" 779: 695:, a global functional service provider headquartered in 677:, a provider of outsourced safety management solutions ( 439:
September 2000: Parexel acquires a majority interest in
849:. The drug had been tested on animals but this was the 269: 1208:"PAREXEL Announces Information Technology Investments" 666:
and trial supply management services headquartered in
511:, for approximately $ 11.9 million in cash and shares. 294:
June 1996: Parexel acquires in separate transactions:
1290:"Parexel Pays $ 148 Million For Three European Firms" 176: 218:, before leaving the company upon retiring in 2018. 2454: 2351: 2225: 874:
Medicines and Healthcare products Regulatory Agency
171: 161: 148: 129: 115: 105: 90: 72: 58: 43: 33: 1819:"Parexel Acquires Heron Group in Up To $ 38M Deal" 425:, only to call off the agreement two months later. 2118:"Window is open for compensation in TGN1412 case" 622:, England, with 731 employees, for $ 182 million. 1760:"Parexel puts up $ 182M for U.K. firm ClinPhone" 1691:. Contineo Media Pte Ltd (Singapore). 2006-10-04 1510:"PERCEPTIVE INFORMATICS ACQUIRES INVANTAGE, INC" 814:In March 2006, a Parexel-run trial on behalf of 1932:"Parexel moves to buy a pharma consulting firm" 1588: 1586: 1458:"Parexel acquires Glaxo's UK pharmacology unit" 1147: 1145: 576:Parexel International Synchron Private Limited. 702:September 2020: Parexel completes purchase of 582:California Clinical Trials Medical Group, Inc. 136:management, data management, medical writing, 2203: 2120:. PharmaTimes. March 14, 2007. Archived from 371:March 1998: Parexel acquires four companies: 8: 2503:Biotechnology companies of the United States 1823:Genetic Engineering & Biotechnology News 984:"PAREXEL Academy Adds Programs for Students" 601:Apex International Clinical Research Co. Ltd 338:a medical marketing business located in the 19: 1029: 1027: 1025: 592:, CA, providing a broad range of specialty 2210: 2196: 2188: 2097:"Will Parexel Settle? TeGenero Litigation" 782:. Please do not remove this message until 564:Synchron Research Services Private Limited 304:-based contract research organization, and 25: 18: 802:Learn how and when to remove this message 529:(IMC), a privately held company based in 1531:"Parexel acquires Pracon & HealthIQ" 778:Relevant discussion may be found on the 2518:Companies formerly listed on the Nasdaq 1716:. Edgemont Capital Partners. 2006-10-12 1685:"Parexel Establishes Presence in India" 889: 319:Lansal Clinical Pharmaceutics, Limited 1324:"PAREXEL Acquires Groupe Pharmedicom" 1120: 1118: 1093: 1091: 7: 2072:"When drug trials go horribly wrong" 1180:"PAREXEL COMPLETES TWO ACQUISITIONS" 681:) with approximately 1500 employees. 586:Behavioral and Medical Research, LLC 472:, a privately held company based in 455:from British pharmaceutical company 346:Sheffield Statistical Services, Ltd. 1741:. PharmaTimes Media Ltd. 2007-10-02 1288:Bulkeley, William M. (1998-03-03). 2268:George Institute for Global Health 325:State and Federal Associates, Inc. 16:American biopharmaceutical company 14: 2160:Clinical trial final report, MHRA 2052:"Drugs trial men 'seriously ill'" 1623:"Parexel acquires marketing firm" 841:, caused severe inflammation and 691:September 2016: Parexel acquires 428:September 1999: Parexel acquires 383:Genesis Pharma Strategies Limited 2508:Companies based in Massachusetts 2076:The International Herald Tribune 1035:"Josef von Rickenbach – Parexel" 900:(Press release). 28 August 2017. 757: 684:February 2016: Parexel acquires 625:December 2012: Parexel acquires 364:December 1997: Parexel acquires 246: 153: 152: 2513:Contract research organizations 1957:"PAREXEL to Acquire ExecuPharm" 1901:Brennan, Zachary (2015-03-26). 1847:Brennan, Zachary (2014-07-02). 1770:American City Business Journals 1664:American City Business Journals 1633:American City Business Journals 1541:American City Business Journals 658:October 2014: Parexel acquires 599:October 2007: Parexel acquires 580:October 2006: Parexel acquires 525:October 2004: Parexel acquires 503:January 2003: Parexel acquires 488:which was then a subsidiary of 480:October 2002: Parexel acquires 468:October 2002: Parexel acquires 308:Sitebase Clinical Systems, Inc. 111:84+ facilities in 51+ countries 63:Clinical research organizations 2219:Contract research organization 614:August 2008: Parexel acquires 609:contract research organization 594:Phase I – IV clinical research 261:format but may read better as 1: 673:April 2015: Parexel acquires 636:April 2013: Parexel acquires 527:Integrated Marketing Concepts 522:, for $ 11.7 million in cash. 402:March 1999: Parexel acquires 355:Hayden Image Processing Group 1930:Garde, Damian (2016-01-21). 1883:. HPCi Media Ltd. 2014-10-06 1877:"Parexel acquires ClinIntel" 1594:"NOTE 18. SUBSEQUENT EVENTS" 647:July 2014: Parexel acquires 559:, for $ 4.8 million in cash. 544:July 2005: Parexel acquires 461:July 2001: Parexel acquires 1911:William Reed Business Media 1857:William Reed Business Media 1462:www.drugdiscoveryonline.com 784:conditions to do so are met 557:Perceptive Informatics Inc. 78:; 42 years ago 2534: 2352:Clinical and Healthcare IT 2243:Charles River Laboratories 2238:Cancer Trials Support Unit 2099:. ClinPage. March 19, 2007 1963:. Rodman Media. 2016-09-27 1153:"PAREXEL Form 10-K (1997)" 818:, the now bankrupt German 746: 574:to a newly formed entity, 445:Bloemfontein, South Africa 379:Parexel MMS Europe Limited 2414:Tata Consultancy Services 2328:WIL Research Laboratories 662:, a provider of clinical 24: 2482:Thermo Fisher Scientific 2293:Labcorp Drug Development 1714:www.edgemontcapital.com/ 1566:PAREXEL Form 10-K (2003) 1765:Boston Business Journal 1659:Boston Business Journal 1628:Boston Business Journal 1536:Boston Business Journal 1378:"Covance, Parexel part" 1295:The Wall Street Journal 912:"PAREXEL – Our Company" 675:Quantum Solutions India 588:, both headquarters in 449:Northwick Park Hospital 404:Groupe PharMedicom S.A. 377:, subsequently renamed 270:converting this section 144:, regulatory consulting 1907:outsourcing-pharma.com 1853:outsourcing-pharma.com 1827:Mary Ann Liebert, Inc. 1598:Parexel Form 10-K 2005 843:multiple organ failure 824:anti-inflammatory drug 743:TGN1412 clinical trial 649:ATLAS Medical Services 607:-based privately held 95:Durham, North Carolina 2477:Syngene International 1512:. PAREXEL. 2002-09-10 1491:. PAREXEL. 2001-07-30 1439:. PAREXEL. 2000-10-16 1412:. PAREXEL. 1999-09-15 1332:. PAREXEL. 1999-04-01 1270:. PAREXEL. 1998-03-02 1243:. PAREXEL. 1997-12-02 1216:. PAREXEL. 1997-11-06 1189:. PAREXEL. 1997-03-03 1161:. PAREXEL. 1997-09-29 1016:"Entrepreneur Briefs" 537:and retention, sales 516:3Clinical Research AG 482:Pracon & HealthIQ 366:Kemper-Masterson, Inc 188:Parexel International 99:Newton, Massachusetts 20:Parexel International 1130:newsroom.parexel.com 1103:newsroom.parexel.com 1059:. 29 September 2017. 851:first test on humans 831:rheumatoid arthritis 550:George, South Africa 423:Covance Parexel Inc. 222:successes in modern 216:Lucerne, Switzerland 157:$ 2.3 billion (2017) 2333:WNS Global Services 2313:PRA Health Sciences 2253:Craven Laboratories 2147:firstwordpharma.com 2124:on January 31, 2013 1075:Private Equity Wire 771:of this section is 697:King of Prussia, PA 686:Health Advances LLC 535:patient recruitment 359:The IRIS Group S.A. 298:Caspard Consultants 238:Acquisition history 163:Number of employees 107:Number of locations 21: 2429:UnitedHealth Group 2409:Oracle Corporation 2399:Medidata Solutions 2338:Wolfe Laboratories 2165:2006-12-06 at the 2143:"FirstWord Pharma" 1881:Cosmetics Business 1356:The New York Times 835:multiple sclerosis 655:with 35 employees. 505:FWPS Group Limited 457:GlaxoWellcome Inc. 375:PPS Europe Limited 272:, if appropriate. 200:biopharmaceuticals 2490: 2489: 2226:Clinical Research 2060:. March 15, 2006. 812: 811: 804: 679:pharmacovigilance 660:ClinIntel Limited 490:Reed Elsevier plc 291: 290: 194:on behalf of its 185: 184: 142:pharmacovigilance 2525: 2263:ePharmaSolutions 2212: 2205: 2198: 2189: 2183:Official website 2170: 2157: 2151: 2150: 2139: 2133: 2132: 2130: 2129: 2114: 2108: 2107: 2105: 2104: 2093: 2087: 2086: 2084: 2083: 2068: 2062: 2061: 2048: 2042: 2041: 2039: 2037: 2027: 2021: 2020: 2018: 2017: 2003: 1997: 1996: 1994: 1993: 1978: 1972: 1971: 1969: 1968: 1953: 1947: 1946: 1944: 1943: 1927: 1921: 1920: 1918: 1917: 1898: 1892: 1891: 1889: 1888: 1873: 1867: 1866: 1864: 1863: 1844: 1838: 1837: 1835: 1834: 1815: 1809: 1808: 1806: 1805: 1787: 1781: 1780: 1778: 1777: 1756: 1750: 1749: 1747: 1746: 1731: 1725: 1724: 1722: 1721: 1706: 1700: 1699: 1697: 1696: 1681: 1675: 1674: 1672: 1671: 1650: 1644: 1643: 1641: 1640: 1619: 1613: 1612: 1610: 1609: 1590: 1581: 1580: 1578: 1577: 1558: 1552: 1551: 1549: 1548: 1527: 1521: 1520: 1518: 1517: 1506: 1500: 1499: 1497: 1496: 1479: 1473: 1472: 1470: 1469: 1454: 1448: 1447: 1445: 1444: 1427: 1421: 1420: 1418: 1417: 1401: 1395: 1394: 1392: 1391: 1374: 1368: 1367: 1365: 1364: 1347: 1341: 1340: 1338: 1337: 1320: 1314: 1313: 1311: 1310: 1285: 1279: 1278: 1276: 1275: 1258: 1252: 1251: 1249: 1248: 1231: 1225: 1224: 1222: 1221: 1204: 1198: 1197: 1195: 1194: 1176: 1170: 1169: 1167: 1166: 1149: 1140: 1139: 1137: 1136: 1122: 1113: 1112: 1110: 1109: 1095: 1086: 1085: 1083: 1082: 1067: 1061: 1060: 1049: 1043: 1042: 1031: 1020: 1019: 1012: 1006: 1005: 1002:Businessweek.com 994: 988: 987: 979: 973: 972: 970: 968: 958: 952: 951: 949: 948: 939:. Archived from 929: 923: 922: 920: 918: 908: 902: 901: 894: 807: 800: 796: 793: 787: 761: 760: 753: 572:Bangalore, India 434:Poitiers, France 340:Washington, D.C. 286: 283: 277: 268:You can help by 250: 249: 242: 181: 178: 156: 155: 86: 84: 79: 29: 22: 2533: 2532: 2528: 2527: 2526: 2524: 2523: 2522: 2493: 2492: 2491: 2486: 2450: 2347: 2221: 2216: 2179: 2174: 2173: 2167:Wayback Machine 2158: 2154: 2141: 2140: 2136: 2127: 2125: 2116: 2115: 2111: 2102: 2100: 2095: 2094: 2090: 2081: 2079: 2078:. April 9, 2006 2070: 2069: 2065: 2050: 2049: 2045: 2035: 2033: 2029: 2028: 2024: 2015: 2013: 2011:www.parexel.com 2005: 2004: 2000: 1991: 1989: 1980: 1979: 1975: 1966: 1964: 1961:Contract Pharma 1955: 1954: 1950: 1941: 1939: 1929: 1928: 1924: 1915: 1913: 1900: 1899: 1895: 1886: 1884: 1875: 1874: 1870: 1861: 1859: 1846: 1845: 1841: 1832: 1830: 1817: 1816: 1812: 1803: 1801: 1789: 1788: 1784: 1775: 1773: 1758: 1757: 1753: 1744: 1742: 1739:pharmatimes.com 1733: 1732: 1728: 1719: 1717: 1708: 1707: 1703: 1694: 1692: 1683: 1682: 1678: 1669: 1667: 1652: 1651: 1647: 1638: 1636: 1621: 1620: 1616: 1607: 1605: 1592: 1591: 1584: 1575: 1573: 1560: 1559: 1555: 1546: 1544: 1529: 1528: 1524: 1515: 1513: 1508: 1507: 1503: 1494: 1492: 1481: 1480: 1476: 1467: 1465: 1456: 1455: 1451: 1442: 1440: 1429: 1428: 1424: 1415: 1413: 1403: 1402: 1398: 1389: 1387: 1376: 1375: 1371: 1362: 1360: 1349: 1348: 1344: 1335: 1333: 1322: 1321: 1317: 1308: 1306: 1287: 1286: 1282: 1273: 1271: 1260: 1259: 1255: 1246: 1244: 1233: 1232: 1228: 1219: 1217: 1206: 1205: 1201: 1192: 1190: 1178: 1177: 1173: 1164: 1162: 1151: 1150: 1143: 1134: 1132: 1124: 1123: 1116: 1107: 1105: 1097: 1096: 1089: 1080: 1078: 1069: 1068: 1064: 1051: 1050: 1046: 1033: 1032: 1023: 1014: 1013: 1009: 1004:. 30 June 2023. 996: 995: 991: 981: 980: 976: 966: 964: 960: 959: 955: 946: 944: 931: 930: 926: 916: 914: 910: 909: 905: 896: 895: 891: 886: 808: 797: 791: 788: 777: 762: 758: 751: 745: 539:lead management 520:Berlin, Germany 486:Excerpta Medica 484:(a division of 287: 281: 278: 267: 251: 247: 240: 212:Schering-Plough 192:clinical trials 175: 164: 121:Peyton Howell ( 118: 108: 82: 80: 77: 65: 48: 17: 12: 11: 5: 2531: 2529: 2521: 2520: 2515: 2510: 2505: 2495: 2494: 2488: 2487: 2485: 2484: 2479: 2474: 2469: 2464: 2458: 2456: 2452: 2451: 2449: 2448: 2443: 2438: 2437: 2436: 2426: 2421: 2416: 2411: 2406: 2401: 2396: 2391: 2386: 2381: 2376: 2371: 2366: 2361: 2355: 2353: 2349: 2348: 2346: 2345: 2340: 2335: 2330: 2325: 2320: 2315: 2310: 2305: 2300: 2295: 2290: 2285: 2280: 2275: 2270: 2265: 2260: 2255: 2250: 2245: 2240: 2235: 2229: 2227: 2223: 2222: 2217: 2215: 2214: 2207: 2200: 2192: 2186: 2185: 2178: 2177:External links 2175: 2172: 2171: 2152: 2134: 2109: 2088: 2063: 2043: 2022: 1998: 1973: 1948: 1922: 1893: 1868: 1839: 1810: 1782: 1751: 1726: 1701: 1689:pharmaasia.com 1676: 1645: 1614: 1582: 1553: 1522: 1501: 1474: 1449: 1422: 1396: 1369: 1342: 1315: 1280: 1253: 1226: 1199: 1171: 1141: 1114: 1087: 1062: 1044: 1021: 1007: 989: 974: 953: 924: 903: 888: 887: 885: 882: 810: 809: 765: 763: 756: 747:Main article: 744: 741: 740: 739: 736: 729: 722: 707: 704:Roam Analytics 700: 693:ExecuPharm Inc 689: 682: 671: 656: 645: 634: 623: 612: 597: 578: 566:, under which 560: 553: 542: 523: 512: 509:Birmingham, UK 501: 478: 466: 459: 437: 426: 415: 400: 399: 398: 392: 386: 369: 362: 351: 350: 349: 343: 330: 329: 328: 322: 313: 312: 311: 305: 289: 288: 254: 252: 245: 239: 236: 196:pharmaceutical 183: 182: 173: 169: 168: 165: 162: 159: 158: 150: 146: 145: 134:clinical trial 131: 127: 126: 119: 116: 113: 112: 109: 106: 103: 102: 92: 88: 87: 74: 70: 69: 67:Pharmaceutical 60: 56: 55: 49: 44: 41: 40: 35: 31: 30: 15: 13: 10: 9: 6: 4: 3: 2: 2530: 2519: 2516: 2514: 2511: 2509: 2506: 2504: 2501: 2500: 2498: 2483: 2480: 2478: 2475: 2473: 2470: 2468: 2465: 2463: 2460: 2459: 2457: 2455:Manufacturing 2453: 2447: 2444: 2442: 2441:Veeva Systems 2439: 2435: 2432: 2431: 2430: 2427: 2425: 2424:Tech Mahindra 2422: 2420: 2417: 2415: 2412: 2410: 2407: 2405: 2402: 2400: 2397: 2395: 2392: 2390: 2387: 2385: 2382: 2380: 2377: 2375: 2372: 2370: 2367: 2365: 2362: 2360: 2357: 2356: 2354: 2350: 2344: 2341: 2339: 2336: 2334: 2331: 2329: 2326: 2324: 2323:Syneos Health 2321: 2319: 2316: 2314: 2311: 2309: 2306: 2304: 2301: 2299: 2296: 2294: 2291: 2289: 2286: 2284: 2281: 2279: 2276: 2274: 2271: 2269: 2266: 2264: 2261: 2259: 2256: 2254: 2251: 2249: 2246: 2244: 2241: 2239: 2236: 2234: 2231: 2230: 2228: 2224: 2220: 2213: 2208: 2206: 2201: 2199: 2194: 2193: 2190: 2184: 2181: 2180: 2176: 2169:, 25 May 2006 2168: 2164: 2161: 2156: 2153: 2148: 2144: 2138: 2135: 2123: 2119: 2113: 2110: 2098: 2092: 2089: 2077: 2073: 2067: 2064: 2059: 2058: 2053: 2047: 2044: 2032: 2026: 2023: 2012: 2008: 2002: 1999: 1987: 1983: 1977: 1974: 1962: 1958: 1952: 1949: 1937: 1936:FierceBiotech 1933: 1926: 1923: 1912: 1908: 1904: 1897: 1894: 1882: 1878: 1872: 1869: 1858: 1854: 1850: 1843: 1840: 1828: 1824: 1820: 1814: 1811: 1799: 1795: 1792: 1786: 1783: 1771: 1767: 1766: 1761: 1755: 1752: 1740: 1736: 1730: 1727: 1715: 1711: 1705: 1702: 1690: 1686: 1680: 1677: 1665: 1661: 1660: 1655: 1649: 1646: 1634: 1630: 1629: 1624: 1618: 1615: 1603: 1599: 1595: 1589: 1587: 1583: 1571: 1567: 1563: 1557: 1554: 1542: 1538: 1537: 1532: 1526: 1523: 1511: 1505: 1502: 1490: 1489: 1484: 1478: 1475: 1463: 1459: 1453: 1450: 1438: 1437: 1432: 1426: 1423: 1411: 1410: 1406: 1400: 1397: 1385: 1384: 1379: 1373: 1370: 1358: 1357: 1352: 1346: 1343: 1331: 1330: 1325: 1319: 1316: 1305: 1301: 1297: 1296: 1291: 1284: 1281: 1269: 1268: 1263: 1257: 1254: 1242: 1241: 1236: 1230: 1227: 1215: 1214: 1209: 1203: 1200: 1188: 1186: 1181: 1175: 1172: 1160: 1159: 1154: 1148: 1146: 1142: 1131: 1127: 1121: 1119: 1115: 1104: 1100: 1094: 1092: 1088: 1076: 1072: 1066: 1063: 1058: 1054: 1048: 1045: 1040: 1036: 1030: 1028: 1026: 1022: 1017: 1011: 1008: 1003: 999: 993: 990: 985: 978: 975: 963: 957: 954: 943:on 2016-04-01 942: 938: 937:MoneyShow.com 934: 928: 925: 913: 907: 904: 899: 893: 890: 883: 881: 879: 875: 871: 867: 862: 860: 854: 852: 848: 844: 840: 836: 832: 828: 825: 822:firm, on its 821: 820:biotechnology 817: 806: 803: 795: 785: 781: 775: 774: 770: 764: 755: 754: 750: 742: 737: 734: 730: 727: 726:Goldman Sachs 723: 720: 716: 712: 708: 705: 701: 698: 694: 690: 687: 683: 680: 676: 672: 669: 665: 664:randomization 661: 657: 654: 650: 646: 643: 639: 635: 632: 628: 624: 621: 617: 616:ClinPhone plc 613: 610: 606: 602: 598: 595: 591: 587: 583: 579: 577: 573: 569: 565: 561: 558: 554: 551: 547: 543: 540: 536: 532: 531:Whitehall, PA 528: 524: 521: 517: 513: 510: 506: 502: 499: 495: 491: 487: 483: 479: 475: 474:Cambridge, MA 471: 470:Invantage Inc 467: 464: 460: 458: 454: 450: 446: 442: 438: 435: 431: 427: 424: 420: 416: 413: 409: 405: 401: 396: 393: 390: 387: 384: 380: 376: 373: 372: 370: 367: 363: 360: 356: 352: 347: 344: 341: 337: 334: 333: 331: 326: 323: 320: 317: 316: 314: 309: 306: 303: 299: 296: 295: 293: 292: 285: 276:is available. 275: 271: 265: 264: 260: 255:This section 253: 244: 243: 237: 235: 233: 232:Goldman Sachs 227: 225: 219: 217: 213: 208: 203: 201: 197: 193: 189: 180: 174: 170: 166: 160: 151: 147: 143: 139: 138:biostatistics 135: 132: 128: 124: 120: 114: 110: 104: 100: 96: 93: 89: 75: 71: 68: 64: 61: 57: 53: 50: 47: 42: 39: 36: 32: 28: 23: 2302: 2155: 2146: 2137: 2126:. Retrieved 2122:the original 2112: 2101:. Retrieved 2091: 2080:. Retrieved 2075: 2066: 2055: 2046: 2034:. Retrieved 2025: 2014:. Retrieved 2010: 2001: 1990:. Retrieved 1988:. 2020-09-22 1985: 1976: 1965:. Retrieved 1960: 1951: 1940:. Retrieved 1935: 1925: 1914:. Retrieved 1906: 1896: 1885:. Retrieved 1880: 1871: 1860:. Retrieved 1852: 1842: 1831:. Retrieved 1822: 1813: 1802:. Retrieved 1794: 1785: 1774:. Retrieved 1772:. 2008-06-13 1763: 1754: 1743:. Retrieved 1738: 1729: 1718:. Retrieved 1713: 1704: 1693:. Retrieved 1688: 1679: 1668:. Retrieved 1666:. 2005-08-22 1657: 1648: 1637:. Retrieved 1635:. 2004-10-04 1626: 1617: 1606:. Retrieved 1604:. 2005-09-08 1597: 1574:. Retrieved 1572:. 2003-09-15 1565: 1556: 1545:. Retrieved 1543:. 2002-11-04 1534: 1525: 1514:. Retrieved 1504: 1493:. Retrieved 1486: 1477: 1466:. Retrieved 1464:. 2000-10-04 1461: 1452: 1441:. Retrieved 1434: 1425: 1414:. Retrieved 1407: 1399: 1388:. Retrieved 1386:. 1999-06-25 1381: 1372: 1361:. Retrieved 1359:. 1999-04-30 1354: 1345: 1334:. Retrieved 1327: 1318: 1307:. Retrieved 1293: 1283: 1272:. Retrieved 1265: 1256: 1245:. Retrieved 1238: 1229: 1218:. Retrieved 1211: 1202: 1191:. Retrieved 1183: 1174: 1163:. Retrieved 1156: 1133:. Retrieved 1129: 1106:. Retrieved 1102: 1079:. Retrieved 1077:. 2017-10-02 1074: 1065: 1056: 1047: 1038: 1010: 1001: 992: 977: 965:. Retrieved 956: 945:. Retrieved 941:the original 936: 927: 915:. Retrieved 906: 892: 863: 855: 813: 798: 789: 767: 703: 692: 685: 674: 659: 648: 637: 627:LIQUENT Inc. 626: 615: 600: 585: 581: 575: 567: 563: 556: 545: 526: 515: 504: 481: 469: 462: 453:Harrow, U.K. 440: 429: 422: 419:Covance Inc. 417:April 1999: 403: 394: 388: 382: 378: 374: 365: 358: 354: 345: 336:RESCON, Inc. 335: 324: 318: 307: 297: 279: 274:Editing help 256: 228: 224:pharmacology 220: 204: 187: 186: 91:Headquarters 34:Company type 2394:LTIMindtree 2343:Wuxi Apptec 1798:Cision Inc. 868:as part of 792:August 2015 668:Crawley, UK 638:Heron Group 631:Horsham, PA 546:Qdot Pharma 54:: PRXL 2497:Categories 2318:Retrogenix 2128:2007-12-18 2103:2007-12-18 2082:2007-12-18 2016:2021-06-10 1992:2020-09-22 1967:2016-12-25 1942:2016-12-25 1916:2016-12-25 1887:2016-12-25 1862:2016-12-25 1833:2016-12-25 1829:2013-05-01 1804:2016-12-25 1800:2012-12-27 1776:2016-12-25 1745:2016-12-25 1720:2016-12-25 1695:2016-12-25 1670:2016-12-25 1639:2016-12-25 1608:2016-12-25 1576:2016-12-25 1547:2016-12-25 1516:2016-12-25 1495:2016-12-25 1488:PRNewswire 1468:2016-12-25 1443:2016-12-25 1436:PRNewswire 1416:2016-12-25 1409:PRNewswire 1390:2016-12-25 1363:2016-12-25 1336:2016-12-25 1329:PRNewswire 1309:2016-12-25 1274:2016-12-25 1267:PRNewswire 1247:2016-12-25 1240:PRNewswire 1220:2016-12-25 1213:PRNewswire 1193:2016-12-25 1185:PRNewswire 1165:2016-12-25 1135:2022-01-04 1108:2022-01-04 1081:2021-01-29 947:2015-09-30 884:References 866:Brian Deer 859:bankruptcy 769:neutrality 715:Queensland 620:Nottingham 498:Orange, CA 494:Reston, VA 430:CEMAF S.A. 395:LOGOS GmbH 389:MIRAI B.V. 117:Key people 2419:Cognizant 2364:Clarivate 2359:Accenture 2308:PPD, Inc. 1938:. Questex 1304:0099-9660 1039:Bilanz.ch 870:Channel 4 839:leukaemia 829:to treat 780:talk page 719:Australia 590:San Diego 342:area, and 282:July 2017 46:Traded as 2404:Merative 2379:Indegene 2278:Icosagen 2273:ICON PLC 2258:Dokumeds 2163:Archived 2057:BBC News 2036:29 March 1383:CNNMoney 967:29 March 917:29 March 878:in vitro 816:TeGenero 773:disputed 711:Brisbane 653:Istanbul 568:Synchron 130:Services 59:Industry 2472:Labcorp 2462:Cencora 2389:Infosys 2384:Informa 2374:HCLTech 2303:Parexel 2298:Medpace 2288:KCR CRO 1986:Parexel 1057:Reuters 827:TGN1412 749:TGN1412 477:trials. 441:FARMOVS 412:Orléans 177:parexel 172:Website 167:18,900 149:Revenue 97:, U.S. 81: ( 73:Founded 38:Private 2467:Cytiva 2248:CLARIO 1302:  847:London 605:Taiwan 463:Edyabe 257:is in 101:, U.S. 52:Nasdaq 2446:Wipro 2434:Optum 2369:Cytel 2283:IQVIA 2233:Calyx 1602:EDGAR 1570:EDGAR 1158:EDGAR 733:Calyx 642:Luton 408:Paris 302:Paris 263:prose 2038:2023 1300:ISSN 969:2023 919:2023 766:The 584:and 496:and 410:and 300:, a 259:list 179:.com 83:1982 76:1982 837:or 451:in 214:in 207:FDA 123:CEO 2499:: 2145:. 2074:. 2054:. 2009:. 1984:. 1959:. 1934:. 1909:. 1905:. 1879:. 1855:. 1851:. 1825:. 1821:. 1796:. 1793:. 1768:. 1762:. 1737:. 1712:. 1687:. 1662:. 1656:. 1631:. 1625:. 1600:. 1596:. 1585:^ 1568:. 1564:. 1539:. 1533:. 1485:. 1460:. 1433:. 1380:. 1353:. 1326:. 1298:. 1292:. 1264:. 1237:. 1210:. 1187:UK 1182:. 1155:. 1144:^ 1128:. 1117:^ 1101:. 1090:^ 1073:. 1055:. 1037:. 1024:^ 1000:. 935:. 853:. 833:, 717:, 713:, 226:. 140:, 2211:e 2204:t 2197:v 2149:. 2131:. 2106:. 2085:. 2040:. 2019:. 1995:. 1970:. 1945:. 1919:. 1890:. 1865:. 1836:. 1807:. 1779:. 1748:. 1723:. 1698:. 1673:. 1642:. 1611:. 1579:. 1550:. 1519:. 1498:. 1471:. 1446:. 1419:. 1393:. 1366:. 1339:. 1312:. 1277:. 1250:. 1223:. 1196:. 1168:. 1138:. 1111:. 1084:. 1041:. 1018:. 986:. 971:. 950:. 921:. 805:) 799:( 794:) 790:( 786:. 776:. 721:. 699:. 670:. 284:) 280:( 266:. 125:) 85:)

Index


Private
Traded as
Nasdaq
Clinical research organizations
Pharmaceutical
Durham, North Carolina
Newton, Massachusetts
CEO
clinical trial
biostatistics
pharmacovigilance
parexel.com
clinical trials
pharmaceutical
biopharmaceuticals
FDA
Schering-Plough
Lucerne, Switzerland
pharmacology
Goldman Sachs
list
prose
converting this section
Editing help
Paris
Washington, D.C.
Paris
Orléans
Covance Inc.

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.